3 New Strong Buy Ratings from Top-Rated Analysts: 05/19/2026

Lucky you: Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

• Electromed Inc (ELMD) — Record Q3 results fuel double-digit growth momentum.
• Garrett Motion Inc (GTX) — Unanimous Strong Buy coverage with 16% upside ahead.
• Aveanna Healthcare Holdings (AVAH) — Home healthcare leader eyes 42% upside potential.

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

The AI That Could Triple Your Money This Year

Early users could have already tripled their money every single year this AI has been live, based on the average winning trade spotted - WITHOUT having to check the news, WITHOUT watching the Fed, and WITHOUT all the stress most traders have to deal with. For now, you can try this AI yourself, completely free of charge - no email, no credit card.

Click to learn more

1. Electromed (NYSEMKT: ELMD)

This innovative medical device maker — armed with its SmartVest airway clearance therapy system — is taking on the underserved bronchiectasis market with serious firepower. Record Q3 2026 results just delivered 18.4% revenue growth and strong operating leverage, positioning ELMD for sustained double-digit growth that has Wall Street paying close attention.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $35.68 — get current quote

Max 1-year forecast: $40.00

Why we're watching:

• Analyst support: While coverage is limited to 2 analysts, it is resoundingly bullish — both are Strong Buy ratings. See the ratings here
• B. Riley Securities researcher Kyle Bauser (a top 21% rated analyst) recently raised the price target to $40 following record Q3 2026 earnings. Bauser noted the quarter's "record" results were highlighted by 18.4% revenue growth and strong operating leverage, delivered by strength in homecare and a hospital rebound, and the company appears positioned for sustained double-digit growth supported by expanding adoption, payer coverage, and a large underpenetrated bronchiectasis market.
• The company delivered a 34.62% EPS beat in Q3 with actual earnings of $0.35 versus estimates of $0.26, while revenue grew 19.20% year-over-year to $18.58 million and beat expectations by 4.35%.
• Management highlighted that 86% of covered lives in the United States are now under contract and manufacturing optimization is complete, positioning the company to capture opportunities in the underserved bronchiectasis market.
• Industry ranking context: ELMD is currently the 2nd highest-rated stock in the Medical Device industry.
• Zen Rating highlights: ELMD is an A-rated stock in our Zen Ratings system, a tier that only includes the top 5% of the 4600+ stocks we track. All of these stocks have passed a rigorous 115-factor review with flying colors.
• Component Grades: The 115 factors we explore are divided into 7 Components, which are graded separately. The company excels with an A grade in Sentiment reflecting strong analyst optimism and an A grade in Financials backed by a healthy 16.2% profit margin and minimal debt-to-equity ratio of 0.21. See all 7 Zen Component Grades here

2. Garrett Motion (NASDAQ: GTX)

The global leader in turbocharger and electric-boosting technologies is making bold moves — a strategic partnership with Ingersoll Rand is ushering in a new era for oil-free industrial innovation, while strong Q1 results just prompted management to raise its 2026 outlook. GTX is firing on all cylinders, and analysts are taking notice.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $30.98 — get current quote

Max 1-year forecast: $36.00

Why we're watching:

• Analyst support: Among the 5 analysts we track issuing ratings on GTX, you’ll see 4 Strong Buy ratings and 1 Buy rating with 0 Hold or Sell ratings, reflecting strong Wall Street confidence. See the ratings
• For example, Stifel Nicolaus' Nathan Jones (a top 2% rated analyst) maintains a Strong Buy rating with the highest price target of $36, representing +16.20% upside potential.
• BWS Financial's Hamed Khorsand (a top 2% rated analyst) maintains a Buy rating with a $32 price target, showing consistent support from top-tier analysts.
• Industry ranking context: GTX is currently the 5th highest-rated stock in the Auto Part industry, which has an Industry Rating of B.
• Zen Rating highlights: With its A (Strong Buy) Ratings, GTX is in a class of stocks that have historically delivered 32.52% annual returns. 
• Component Grades: The company demonstrates balanced strength with B grades in Momentum and Safety, which is bolstered and supported by solid operational cash flow of $455M and strong earnings growth forecasts. See all 7 Zen Component Grades here

3. Aveanna Healthcare Holdings (NASDAQ: AVAH)

This nationwide home healthcare powerhouse — covering private duty nursing, adult home health and hospice, pediatric therapy, and enteral nutrition services — is firing on all cylinders. AVAH just topped Q1 2026 earnings and revenue estimates, announced revised 2026 guidance, and scored a fresh Strong Buy upgrade from Stephens & Co. that's putting it squarely on Wall Street's radar. 

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $7.72 — get current quote

Max 1-year forecast: $11.00

Why we're watching:

• Analyst support: AVAH enjoys 2 Strong Buy, 1 Buy, and 3 Hold ratings among the analysts we track — an overall Buy consensus. See the ratings
• Stephens & Co. researcher Scott Fidel (a top 15% rated analyst) recently upgraded the stock to Strong Buy with a price target of $11, representing +42.49% upside potential.
• Even the Hold ratings suggest upside, though. RBC Capital's Ben Hendrix (a top 13% rated analyst) maintains a Hold rating but with a $10 price target that still implies +29.53% upside, suggesting potential for rating upgrades ahead. 
• Industry ranking context: AVAH is currently the 3rd highest-rated stock in the Medical Care Facility industry, which has an Industry Rating of A, placing it in an attractive sector.
• Zen Rating highlights: AVAH earns an overall Zen Rating of A, putting it in the top tier of stocks we track based on a rigorous 115-factor review. Stocks in this category have historically delivered market-beating returns. 
• Component Grades: Looking at the Component Grades that shape the overall rating, the stock shines with an A grade in Sentiment reflecting strong analyst optimism post-earnings and a B grade in Value, suggesting a potentially attractive entry point. See all 7 Zen Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.